A detailed history of Steward Partners Investment Advisory, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,413 shares of EXAS stock, worth $89,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,413
Previous 1,262 11.97%
Holding current value
$89,245
Previous $53,000 81.13%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $6,406 - $10,695
151 Added 11.97%
1,413 $96,000
Q2 2024

Aug 08, 2024

SELL
$41.33 - $74.26 $145,605 - $261,617
-3,523 Reduced 73.63%
1,262 $53,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $8,665 - $11,360
154 Added 3.33%
4,785 $330,000
Q4 2023

Feb 12, 2024

BUY
$59.06 - $75.72 $206,237 - $264,414
3,492 Added 306.58%
4,631 $342,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $1,978 - $2,971
30 Added 2.71%
1,139 $77,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $8,148 - $12,356
-130 Reduced 10.49%
1,109 $104,000
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $10,193 - $15,286
216 Added 21.11%
1,239 $84,000
Q4 2022

Feb 15, 2023

BUY
$30.35 - $53.15 $3,247 - $5,687
107 Added 11.68%
1,023 $50,000
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $7,960 - $12,293
249 Added 37.33%
916 $30,000
Q2 2022

Aug 04, 2022

BUY
$35.61 - $76.23 $7,300 - $15,627
205 Added 44.37%
667 $26,000
Q1 2022

May 02, 2022

SELL
$57.56 - $82.54 $182,119 - $261,156
-3,164 Reduced 87.26%
462 $32,000
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $221,415 - $307,476
3,054 Added 533.92%
3,626 $282,000
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $101,340 - $150,690
-1,082 Reduced 65.42%
572 $71,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $122,165 - $162,450
1,048 Added 172.94%
1,654 $217,000
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $5,876 - $8,385
59 Added 10.79%
606 $80,000
Q3 2020

Oct 30, 2020

SELL
$72.92 - $102.01 $11,594 - $16,219
-159 Reduced 22.52%
547 $56,000
Q2 2020

Aug 06, 2020

BUY
$55.75 - $92.75 $6,968 - $11,593
125 Added 21.51%
706 $61,000
Q1 2020

Apr 29, 2020

BUY
$37.9 - $104.44 $3,183 - $8,772
84 Added 16.9%
581 $33,000
Q4 2019

Jan 17, 2020

BUY
$77.66 - $99.74 $21,744 - $27,927
280 Added 129.03%
497 $45,000
Q3 2019

Oct 30, 2019

BUY
$90.37 - $122.49 $1,355 - $1,837
15 Added 7.43%
217 $19,000
Q2 2019

Jul 25, 2019

BUY
$89.51 - $118.04 $18,081 - $23,844
202 New
202 $23,000
Q4 2018

Jan 15, 2019

SELL
$56.04 - $82.66 $31,158 - $45,958
-556 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$48.29 - $80.6 $14,487 - $24,180
-300 Reduced 35.05%
556 $44,000
Q2 2018

Jul 20, 2018

SELL
$37.84 - $69.96 $3,784 - $6,995
-100 Reduced 10.46%
856 $51,000
Q1 2018

Apr 20, 2018

BUY
$39.82 - $57.53 $3,464 - $5,005
87 Added 10.01%
956 $38,000
Q4 2017

Jan 19, 2018

BUY
$46.49 - $60.51 $40,399 - $52,583
869
869 $45,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.